September 29, 2020
Configuring socially distanced lab spaces for 2,900 general chemistry students was logistically impossible, so Purdue University’s beginning chemistry labs are taking place online this fall, the next best thing to being there. Or maybe better.
September 28, 2020
Every weekday at 8:30 a.m., Purdue President Mitch Daniels convenes a meeting to review the status of COVID-19 at Purdue. David Broecker, who attends the meetings and leads the health monitoring and surveillance group of the Protect Purdue Implementation Team, said members pore over a data dashboard to view trends in testing, determine residential infection “hot-spots” and discuss administrative decisions.
September 28, 2020
Mobile Plexiglas barriers have been installed in most the standard learning spaces on campus, which has led some to question how effective they are. “(Plexiglas) is good at preventing direct contact of droplets,” said David Sanders, a professor in the College of Science who specializes in research on the ways viruses enter cells. He added that it acts as a barrier between individuals having a conversation.
September 28, 2020
Clostridioides difficile (C. diff) is one of only four bacteria considered to be an urgent threat by the US Centers for Disease Control and Prevention (CDC). This is because the two US Food and Drug Administration (FDA) antibiotics currently approved to treat it both (vancomycin and fidaxomicin) have high rates of treatment failure and infection recurrence. As a result, new antibacterial therapies with efficacy against C. diff and novel mechanisms of action are in high demand.
September 24, 2020
Clostridioides difficile, or C. diff, is the leading cause of health care-associated infection in the U.S. Only two antibiotics, vancomycin and fidaxomicin, are FDA-approved for the treatment of C. diff, but even these therapies suffer from high treatment failure and recurrence.
Ultrapotent compound may help treat C. diff, reduce recurrence
September 16, 2020
Today, the Gordon and Betty Moore Foundation announced the 2020 cohort of Moore Inventor Fellows. The fellowship supports scientist-inventors who create new tools and technologies with a high potential to accelerate progress in the foundation’s areas of interest: scientific discovery, environmental conservation and patient care.
Gordon and Betty Moore Foundation Announces 2020 Moore Inventor Fellows
September 16, 2020
Just like many people start to sneeze in the fall, horses also can be affected by seasonal allergies. Sometimes, this is apparent by coughing, but other times, according to Laurent Couëtil, professor of large animal internal medicine in Purdue University’s College of Veterinary Medicine, the only sign is that their performance suffers.
September 16, 2020
As a sixth-grader, Emma Lendy was the only girl in her class to choose the category, How Things Work, for her science project. In helping her build a telegraph, Lendy said her father, a mechanical engineer, “fostered my interest in delving into why things work, not just taking them for granted.”
As pandemic persists, student’s research holds new importance
September 15, 2020
Last fall in Plant Structure & Tissue Biology, Mia Brann and her classmates called over teaching assistants and their instructor to help determine if they had correctly focused on the plant cells they had just loaded into their microscopes. The 22 students pulled their faces from the scopes as TAs stepped in and pressed their eyes to the lenses to offer guidance.
September 15, 2020
Just as many humans start to sneeze in the fall, horses also can be affected by seasonal allergies. Sometimes this is apparent by coughing, but other times, according to Laurent Couëtil, professor of large animal internal medicine in Purdue University’s College of Veterinary Medicine, the only sign is that their performance suffers.
Fall allergies can trigger horses’ asthma, impact performance
